The role of coronary reactivity testing in women with no obstructive coronary artery disease.

ABSTRACT:

Purpose of review

Two-thirds of women with signs and symptoms of ischemia and no obstructive coronary artery disease (INOCA) have abnormal coronary reactivity. These women are challenging to assess, diagnose and manage because of a lack of evidence-based guidelines. Furthermore, they are considered to be at 'low risk' by most physicians, often receive no specific therapy and tend to be dismissed from subspecialty care.

Recent findings

Coronary reactivity testing (CRT) is considered the reference-standard for evaluation of epicardial and microvascular coronary function in response to various vasoactive agents. It provides a comprehensive vascular function assessment for diagnosis, a guide for management, and has prognostic benefit that outweighs the risk of the procedure. We

SUBMITTER: AlBadri A 

PROVIDER: S-EPMC7156026 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature